Document is current
Any future updates will be listed below
-
Authors
Baljevic, Muhamed https://orcid.org/0000-0002-0630-8458
Sborov, Douglas W.
- License Information
-
More Information
Article History
Received: 26 June 2023
Revised: 5 July 2023
Accepted: 13 July 2023
First Online: 25 August 2023
Competing interests
: MB—Consultancy: Cardinal Health, AbbVie. Advisory Boards: Janssen Biotech, Karyopharm, BMS/Celgene. Speaker: NCCN, Curio Science, Targeted Oncology. IRCs: Parexel. DWS—IRC: Paraxel. Advisory/consultancy: Pfizer, bioline, Janssen, BMS, Sanofi, A rcellx.
Free to read: This content has been made available to all.
